Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Azithromycin and Cefuroxime in AECB
NCT00132938Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Primary completion
- May 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 8
01
Overview
Phase 4, randomised, open-label trial of telithromycin in chronic bronchitis (CB) (3 arms), sponsored by Sanofi. Primary endpoint: Presence of Penicillin or Erythromycin Resistant Streptococcus pneumoniae. Started Jan 2004; status: completed.
02
Drugs
telithromycin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00132938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132938.